Compare PCTY & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCTY | BIO |
|---|---|---|
| Founded | 1997 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 7.2B |
| IPO Year | 2014 | N/A |
| Metric | PCTY | BIO |
|---|---|---|
| Price | $106.29 | $278.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 4 |
| Target Price | $180.24 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 1.1M | 289.2K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.74 | N/A |
| EPS | ★ 1.77 | N/A |
| Revenue | ★ $1,595,221,000.00 | N/A |
| Revenue This Year | $11.08 | $2.31 |
| Revenue Next Year | $8.01 | $3.10 |
| P/E Ratio | $63.54 | ★ $9.72 |
| Revenue Growth | ★ 13.74 | N/A |
| 52 Week Low | $100.90 | $211.43 |
| 52 Week High | $210.35 | $343.12 |
| Indicator | PCTY | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 35.90 | 45.27 |
| Support Level | $101.40 | $266.71 |
| Resistance Level | $152.53 | $290.01 |
| Average True Range (ATR) | 4.99 | 9.32 |
| MACD | 0.71 | 0.34 |
| Stochastic Oscillator | 27.74 | 57.28 |
Founded in 1997, Paylocity is a cloud-based human capital management and payroll platform servicing midmarket customers. The company's average client size is around 150 employees. Its products help with recruiting and onboarding, payroll, time and labor, human resources, benefits, learning, and performance and compensation workflows. In fiscal 2025, the company generated over $1.5 billion in revenue across more than 41,000 customers.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.